Neurophoenix

📍 Paris, France🗓 Founded 2018👥 2 employees💰 Last funded Nov 2021
Biotechnology Research🌐 neurophoenix.fr
Website LinkedIn
Neurophoenix is a preclinical stage biotech company advancing its rabies virus biomimicry based PTEN inactivation compounds to unlock neuron repair in optic neuropathies (NAION, glaucoma) and several other neuronal diseases.
1
Total investors
0
Early stage
1
Mid stage
0
Late stage
2018
Founded

Investors

1 investors
All
Early stage
Mid stage
Late stage
Investor geography1 country
France
1
Frequently asked questions
Who invested in Neurophoenix?
Neurophoenix has 1 investors on record on gritt.io, 1 mid-stage.
When did Neurophoenix last raise funding?
The most recent investment in Neurophoenix recorded on gritt.io was in November 2021.
When was Neurophoenix founded?
Neurophoenix was founded in 2018.
What industry is Neurophoenix in?
Neurophoenix operates in Biotechnology Research. Find similar Biotechnology Research investors on gritt.io.
Where is Neurophoenix based?
Neurophoenix is headquartered in Paris, France.